A rare case of incidental asymptomatic emphysematous cystitis in a patient taking empagliflozin

服用恩格列净的患者中罕见的偶然发现的无症状性气肿性膀胱炎病例

阅读:2

Abstract

Emphysematous cystitis (EC) is an uncommon and potentially serious urinary tract infection (UTI) characterized by gas formation within the bladder wall or lumen, frequently observed in patients with diabetes mellitus (DM). We report the case of a 76-year-old female with a history of atrial fibrillation (aFib) and heart failure (HF), who was incidentally diagnosed with EC on imaging during the evaluation of transient gross hematuria. She was clinically asymptomatic, with negative urine and blood cultures, and no systemic signs of infection. Notably, she was taking empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor. The patient was managed conservatively with antibiotics, foley catheterization, and discontinuation of empagliflozin, with complete radiographic resolution of EC. This case highlights the hypothesis of potential association between SGLT2 inhibitors and EC. In our case, conservative treatment and removal of empagliflozin led to a complete resolution of EC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。